Tag #Opioid Crisis

Showing 73 to 84 of 105 results

edition.cnn.com

🌐 85% Global Worthiness

Jan 31, 07:09

FDA Approves First New Pain Reliever in Over Two Decades

The FDA approved Journavx (suztrigine), a new non-opioid pain reliever, offering a safer alternative to opioids; clinical trials showed effectiveness in reducing post-surgical pain, but further research is needed for chronic pain.

FDA Approves First New Pain Reliever in Over Two Decades

The FDA approved Journavx (suztrigine), a new non-opioid pain reliever, offering a safer alternative to opioids; clinical trials showed effectiveness in reducing post-surgical pain, but further research is needed for chronic pain.

Progress

48% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What is the significance of the FDA's approval of Journavx, and how does it address the current healthcare landscape?

The FDA approved Journavx (suztrigine), a new non-opioid pain reliever, offering an alternative to opioids. This 50mg pill, taken every 12 hours after a larger initial dose, showed effectiveness in reducing pain after surgeries in clinical trials. About half of the 80 million Americans who receive prescriptions for moderate to severe pain annually receive opioid-based medications, highlighting the need for safer alternatives.

aljazeera.com

🌐 90% Global Worthiness

Jan 24, 01:09

\$7.4 Billion Settlement Reached in Purdue Pharma Opioid Lawsuits

Purdue Pharma and the Sackler family agreed to pay up to \$7.4 billion to settle lawsuits over the opioid crisis caused by OxyContin, exceeding a prior rejected settlement by more than \$1 billion; the Sacklers will contribute up to \$6.5 billion, Purdue \$900 million, and the funds will compensate ...

\$7.4 Billion Settlement Reached in Purdue Pharma Opioid Lawsuits

Purdue Pharma and the Sackler family agreed to pay up to \$7.4 billion to settle lawsuits over the opioid crisis caused by OxyContin, exceeding a prior rejected settlement by more than \$1 billion; the Sacklers will contribute up to \$6.5 billion, Purdue \$900 million, and the funds will compensate ...

Progress

44% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What is the total amount of the settlement, and how does it compare to previous attempts, and what are the immediate implications?

Purdue Pharma and the Sackler family will pay up to \$7.4 billion to settle lawsuits related to the opioid crisis caused by OxyContin. This is \$1 billion more than a previous rejected settlement. The Sacklers will pay up to \$6.5 billion, and Purdue will contribute \$900 million.

apnews.com

🌐 90% Global Worthiness

Jan 23, 22:08

Sackler Family Agrees to $7.4 Billion Opioid Settlement

The Sackler family and Purdue Pharma agreed to a $7.4 billion settlement over opioid crisis lawsuits, with the Sacklers paying up to $6.5 billion and relinquishing company ownership, exceeding a previous, rejected deal.

Sackler Family Agrees to $7.4 Billion Opioid Settlement

The Sackler family and Purdue Pharma agreed to a $7.4 billion settlement over opioid crisis lawsuits, with the Sacklers paying up to $6.5 billion and relinquishing company ownership, exceeding a previous, rejected deal.

Progress

40% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What is the immediate impact of the $7.4 billion settlement on the opioid crisis?

The Sackler family, owners of Purdue Pharma (OxyContin's maker), agreed to a $7.4 billion settlement to resolve lawsuits stemming from the opioid crisis. This includes a $6.5 billion payment from the Sacklers and nearly $900 million from Purdue. The settlement surpasses a previous deal, adding $500 million more from the family.

cnn.com

🌐 85% Global Worthiness

Jan 23, 22:08

Sackler Family, Purdue Pharma Settle Opioid Lawsuits for $7.4 Billion

Purdue Pharma and the Sackler family agreed to a $7.4 billion settlement to resolve lawsuits claiming their opioid painkiller OxyContin fueled the U.S. opioid crisis, following a Supreme Court ruling that overturned a previous bankruptcy deal that granted the Sacklers immunity.

Sackler Family, Purdue Pharma Settle Opioid Lawsuits for $7.4 Billion

Purdue Pharma and the Sackler family agreed to a $7.4 billion settlement to resolve lawsuits claiming their opioid painkiller OxyContin fueled the U.S. opioid crisis, following a Supreme Court ruling that overturned a previous bankruptcy deal that granted the Sacklers immunity.

Progress

36% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What role did the Supreme Court play in shaping this settlement?

The $7.4 billion settlement resolves lawsuits alleging deceptive marketing of OxyContin, contributing to the opioid crisis and over 700,000 overdose deaths. The Sacklers, while denying wrongdoing, expressed regret. This is part of a broader trend of opioid manufacturers facing massive payouts.

cbsnews.com

🌐 85% Global Worthiness

Jan 18, 04:06

Justice Department Sues Walgreens for Filling Millions of Unlawful Opioid Prescriptions

The U.S. Department of Justice filed a lawsuit against Walgreens on Friday, accusing the company of knowingly filling millions of unlawful opioid prescriptions from August 2012 to the present, ignoring red flags and pressuring pharmacists to fill prescriptions rapidly, resulting in millions of opioi...

Justice Department Sues Walgreens for Filling Millions of Unlawful Opioid Prescriptions

The U.S. Department of Justice filed a lawsuit against Walgreens on Friday, accusing the company of knowingly filling millions of unlawful opioid prescriptions from August 2012 to the present, ignoring red flags and pressuring pharmacists to fill prescriptions rapidly, resulting in millions of opioi...

Progress

40% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How did Walgreens' alleged actions contribute to the broader opioid crisis, and what internal and external factors facilitated these practices?

This lawsuit connects to a broader pattern of legal action against pharmacies for their role in the opioid crisis. The Justice Department's claim that Walgreens ignored internal warnings and pressured pharmacists mirrors allegations in similar lawsuits against other pharmacy chains, highlighting systemic issues within the industry's opioid dispensing practices. Four whistleblowers, former Walgreens employees, further support these claims.

theglobeandmail.com

🌐 75% Global Worthiness

Jan 2, 13:08

Canadian Drug Overdose Deaths Fall in First Half of 2024

Preliminary data shows an 11 percent decrease in Canadian opioid-related deaths in the first half of 2024 compared to the same period in 2023, with Alberta, British Columbia, and Ontario showing significant reductions, although some provinces experienced increases. This follows a similar trend in th...

Canadian Drug Overdose Deaths Fall in First Half of 2024

Preliminary data shows an 11 percent decrease in Canadian opioid-related deaths in the first half of 2024 compared to the same period in 2023, with Alberta, British Columbia, and Ontario showing significant reductions, although some provinces experienced increases. This follows a similar trend in th...

Progress

36% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

Which provinces experienced increases in drug-related deaths in 2024, and what are the potential explanations for these exceptions?

The decrease in Canadian drug overdose deaths may be attributed to several factors: changes in the drug market, increased access to naloxone and addiction services, and altered drug use behaviors. The decline follows a similar trend in the United States, where overdose deaths dropped by approximately 17 percent. However, inconsistencies in data collection and limited inter-agency collaboration hinder a complete understanding of the situation.

foxnews.com

🌐 90% Global Worthiness

Jan 30, 19:11

Bipartisan Senate Bill Seeks to Permanently Classify Fentanyl as Schedule I Drug

Sens. Cassidy, Grassley, and Heinrich reintroduced the bipartisan HALT Fentanyl Act to permanently classify fentanyl-related substances as Schedule I drugs, aiming to curb the national opioid crisis and the nearly 108,000 overdose deaths between August 2021 and 2022, with the current temporary class...

Bipartisan Senate Bill Seeks to Permanently Classify Fentanyl as Schedule I Drug

Sens. Cassidy, Grassley, and Heinrich reintroduced the bipartisan HALT Fentanyl Act to permanently classify fentanyl-related substances as Schedule I drugs, aiming to curb the national opioid crisis and the nearly 108,000 overdose deaths between August 2021 and 2022, with the current temporary class...

Progress

40% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What is the primary aim of the HALT Fentanyl Act, and what immediate impact could its passage have on the national opioid crisis?

The HALT Fentanyl Act, reintroduced by Senators Cassidy, Grassley, and Heinrich, seeks to permanently classify fentanyl-related substances as Schedule I drugs. This measure is crucial because the current temporary classification expires on March 31st, and fentanyl overdoses are the leading cause of death for young adults (18-45). The bill's passage is highly likely due to Senator Grassley's chairmanship of the Senate Judiciary Committee.

kathimerini.gr

🌐 85% Global Worthiness

Jan 24, 01:09

Sackler Family and Purdue Pharma to Pay $7.4 Billion in Opioid Crisis Settlement

Purdue Pharma and the Sackler family will pay $7.4 billion to settle lawsuits from 15 states over their role in the opioid crisis; the Sacklers will pay $6.5 billion over 15 years, and Purdue Pharma $900 million, following a Supreme Court rejection of a previous settlement that granted the Sacklers ...

Sackler Family and Purdue Pharma to Pay $7.4 Billion in Opioid Crisis Settlement

Purdue Pharma and the Sackler family will pay $7.4 billion to settle lawsuits from 15 states over their role in the opioid crisis; the Sacklers will pay $6.5 billion over 15 years, and Purdue Pharma $900 million, following a Supreme Court rejection of a previous settlement that granted the Sacklers ...

Progress

48% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What factors contributed to the Supreme Court's rejection of the previous 2022 settlement?

This settlement resolves claims against Purdue Pharma and the Sackler family for aggressively marketing OxyContin, a highly addictive painkiller, despite knowing its risks. The settlement comes after years of litigation and reflects the significant human and economic costs of the opioid crisis in the US, where over 700,000 deaths have been linked to opioid overdoses since 1999.

theglobeandmail.com

🌐 85% Global Worthiness

Jan 23, 04:13

Canadian Court Certifies Class-Action Lawsuit Against Opioid Companies

A British Columbia Supreme Court judge certified a class-action lawsuit against over 40 opioid companies for allegedly over-promoting prescription opioid use, leading to substantial public health care costs; the B.C. government, joined by all other Canadian governments, alleges wrongful conduct and ...

Canadian Court Certifies Class-Action Lawsuit Against Opioid Companies

A British Columbia Supreme Court judge certified a class-action lawsuit against over 40 opioid companies for allegedly over-promoting prescription opioid use, leading to substantial public health care costs; the B.C. government, joined by all other Canadian governments, alleges wrongful conduct and ...

Progress

44% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How does the court's decision to certify the class action address the systemic nature of the opioid crisis in Canada?

This class-action lawsuit connects the over-promotion of opioids by pharmaceutical companies to the significant healthcare costs associated with Canada's opioid crisis. The court's decision to certify the class action acknowledges the systemic nature of the problem, enabling a more efficient approach to addressing the widespread harm caused. The ruling is particularly significant given the scale of the opioid crisis in Canada, with nearly 50,000 deaths since 2016.

forbes.com

🌐 90% Global Worthiness

Jan 18, 22:08

Justice Department Sues Walgreens for Dispensing Millions of Illegal Opioid Prescriptions

The Justice Department filed a civil lawsuit against Walgreens, alleging that from August 2012 to the present, they knowingly dispensed millions of illegal opioid prescriptions, ignoring red flags and pressuring pharmacists to fill prescriptions quickly, contributing to the opioid crisis and resulti...

Justice Department Sues Walgreens for Dispensing Millions of Illegal Opioid Prescriptions

The Justice Department filed a civil lawsuit against Walgreens, alleging that from August 2012 to the present, they knowingly dispensed millions of illegal opioid prescriptions, ignoring red flags and pressuring pharmacists to fill prescriptions quickly, contributing to the opioid crisis and resulti...

Progress

40% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How did Walgreens' alleged actions contribute to the broader opioid crisis and the high rate of opioid overdose deaths?

Walgreens allegedly pressured pharmacists to fill prescriptions quickly, disregarding warnings about potentially invalid prescriptions. This systematic disregard for legal requirements and patient safety, combined with the high rate of opioid overdose deaths, highlights a critical failure in the pharmaceutical industry's regulatory oversight and enforcement.

edition.cnn.com

🌐 85% Global Worthiness

Jan 16, 10:09

Chinese Nationals on Trial in Landmark Fentanyl Trafficking Case

Two Chinese citizens stand trial in New York for trafficking over 200 kg of fentanyl precursor chemicals from China, enough to kill 25 million, underscoring the scale of the operation and challenges in combating the global opioid crisis.

Chinese Nationals on Trial in Landmark Fentanyl Trafficking Case

Two Chinese citizens stand trial in New York for trafficking over 200 kg of fentanyl precursor chemicals from China, enough to kill 25 million, underscoring the scale of the operation and challenges in combating the global opioid crisis.

Progress

40% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How effective have China's efforts to control fentanyl precursors been, and what challenges remain?

The case against Wang and Chen underscores the challenges in controlling the international fentanyl trade. While China has taken steps to regulate fentanyl-related substances, the ability of manufacturers to slightly alter chemical compounds to evade regulations remains a significant hurdle. This case demonstrates the need for enhanced international cooperation and stricter enforcement to curb the supply of these deadly precursors.

aljazeera.com

🌐 85% Global Worthiness

Dec 24, 01:07

Fentanyl Drives Opioid Deaths in Canada Despite Overall Decrease

Between January 2016 and June 2024, nearly 50,000 Canadians died from opioid overdoses; fentanyl was responsible for 49,105 deaths, showing a 39 percent increase since 2016 despite an 11 percent decrease in overall opioid overdose deaths in 2024 compared to 2023; increased domestic production and ex...

Fentanyl Drives Opioid Deaths in Canada Despite Overall Decrease

Between January 2016 and June 2024, nearly 50,000 Canadians died from opioid overdoses; fentanyl was responsible for 49,105 deaths, showing a 39 percent increase since 2016 despite an 11 percent decrease in overall opioid overdose deaths in 2024 compared to 2023; increased domestic production and ex...

Progress

36% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What is the immediate impact of the increase in fentanyl-related deaths in Canada, and how does this affect the overall opioid crisis?

From January 2016 to June 2024, nearly 50,000 Canadians died from opioid overdoses, with fentanyl accounting for 49,105 of these deaths. This represents a significant increase, with fentanyl comprising 79 percent of opioid deaths in 2024, a 39 percent rise since 2016. The overall opioid overdose rate has, however, decreased by 11 percent in 2024 compared to 2023.

Showing 73 to 84 of 105 results